2005論文

1	Ischemic preconditionig protects post-ischemic renal function in anesthetized dogs:role of adenosine and adenine nucleotides. Li FZ, Kimura S, Nishiyama A, Rahman M, Zhang GX and Abe Y. Acta Pharmacol Sin. 26: 851-859, 2005.
2	Aldosterone stimulates reactive oxygen spices production thorough the activation of NADPH oxidase in rat mesangial cells. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang G-X, Sun G-P, Kimura S, Kiyomoto H, Kohno M, Yukimura T, Abe Y and Nishiyama A. J. Am. Soc. Nephrol. 16: 2906-2912, 2005.
3	Aldosterone stimulates collagen gene expression and synthesis via activation of extracellular signal-regulated kinases in renal fibroblasts. Nagai Y, Miyata K, Sun G-P, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M and Nishiyama A. Hypertension. 46: 1039-1045, 2005.
4	Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A and Yoshizumi M. Hypertension. 46: 1046-1052, 2005.
5	D-allose, an all-cis aldo-hexose, suppresses development of salt-induced hypertension in Dahl rats. Kimura S, Zhang G-X, Nishiyama A, Nagai Y, Nakagawa T, Miyanaka H, Fujisawa Y, Miyatake A, Nagai T, Tokuda M and Abe Y. J. Hypertens. 23: 1887-1894, 2005.
6	Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. Kobori H, Ozawa Y, Suzaki Y and Nishiyama A. J. Am. Soc. Nephrol. 16: 2073-2080, 2005.
7	Angiotensin II type 1 receptor inhibition reduces cerebral edema and decreases matrix metallopproteinases following transient focal cerebral ischemia. Hosomi N, Nishiyama A, Guo P, Ban CR, Naya T, Takahashi T, Kohno M and Koziol JA. Neuroscience. 134: 225-231, 2005.
8	Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Kimura S, Zhang G-X, Nishiyama A, Shokoji T, Yao L, Fan Y-Y, Rahman M, Suzuki T, Maeta H and Abe Y. Hypertension. 45: 860-866, 2005.
9	Involvement of aldosterone and mineralocorticoid receptor in rat mesangial cell proliferation and deformability. Nishiyama A, Yao L, Fan Y-Y, Kyaw M, Kataoka N, Hashimoto K, Nagai Y, Nakamura E, Yoshizumi M, Shokoji T, Kimura S, Kiyomoto H, Tsujioka K, Kohno M, Tamaki T, Kajiya F and Abe Y. Hypertension. 45: 710-716, 2005.
10	Mitochondria-derived reactive oxygen species and vascular MAP kinases: Comparison of angiotensin II and diazoxide. Kimura S, Zhang G-X, Nishiyama A, Shokoji T, Yao L, Fan Y-Y, Rahman M and Abe Y. Hypertension. 45: 438-444, 2005.
11	Temporary angiotensin blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y and Nishiyama A. J. Am. Soc. Nephrol. 16: 703-711, 2005.
12	Superoxide scavenging attenuates renal responses to angiotensin II during nitric oxide inhibition in anesthetized dogs. Majid DSA, Nishiyama A, Jackson KE and Castillo A. Am. J. Physiol. Renal Physiol. 288: F412-F419, 2005.
13	Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A and Abe Y. Cardiovasc. Res. 65: 230-238, 2005.
14	Enhanced expression of prorenin receptor in the non-clipped kidney of 2K1C Goldblatt hypertensive rats. T Takemitsu, A Ichihara, Y Kaneshiro, M Sakoda, A Nishiyama, F Suzuki, T Nakagawa, T Inagami, M Hayashi. HYPERTENSION 46(4) 824 - 824 2005.
15	Direct demonstration of preload dependency of myocardial flow reserve in human failing heart by 15O-H2O positron emission tomography. Hiroyuki Takinami, Yasuyoshi Iwado, Koji Ohmori, Katsufumi Mizushige, Yoshihiro Nisiyama, Motoomi Okawa, Chietugu Kato, Nagara Tamaki, Shoichi Senda, Masakazu Kohno. International Journal of Angiology 14(3) 133 - 137 2005.
16	"Receptor-associated prorenin system" contributes to hypertensive end-organ damage. A Ichiara, Y Kaneshiro, T Takemitsu, F Suzuki, T Nakagawa, A Nishiyama, H Iwata, Y Ishida, T Inagami, T Saruta, M Hayashi. JOURNAL OF HYPERTENSION 23 S78 - S78 2005.
17	Effects of AT1 receptor blockade on oxidative stress and uncoupling protein-2 expression in rat hypertensive heart failure. P Guo, A Nishiyama, M Rahman, M Ishizawa, K Murakami, A Miyatake, K Ohmori, K Mizushige, Y Abe, T Noma, M Kohno. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 45(3) 165A - 166A 2005.
18	Reno-protective effects of aldosterone blockade. A Nishiyama, Y Abe. JOURNAL OF PHARMACOLOGICAL SCIENCES 97 54P - 54P 2005.
19	Angiotensin type 1 receptor block age improves ischemic injury following transient focal cerebral ischemia. N Hosomi, A Nishiyama, CR Ban, T Naya, T Takahashi, M Kohno, JA Koziol. NEUROSCIENCE 134(1) 225 - 231 2005.
20	Role of aldosterone in the kidney. NISHIYAMA,Akira, ABE,Youichi. Hypertension Frontier. (8) 47 - 59 2005.
21	Potential roles of interstitial fluid adenosine in the regulation of renal hemodynamics. Akira Nishiyama, Youichi Abe. Advances in Neuroregulation and Neuroprotection 834 - 849 2005.